is the cost of glp 1 going down Putting Medical Costs on a Diet: Why Payers Have GLP-1s All Wrong A Heavy Price: The Economic

Fifteen months after initial therapy, the patients oncologist reported that the patient had no signs of progressive cancer

During beta-oxidation, they produce propionyl-CoA as their final breakdown product rather than the acetyl-CoA that even-chain fatty acids generate

Although low-affinity mAbs have low efficacy, high-affinity mAbs might demonstrate more adverse events due to binding to all EpCAM+ cells

Fibrinogen promotes atherosclerosis by increasing inflammation, inducing expression of immune cell adhesion molecules on blood vessel surfaces, and stimulating vascular smooth muscle cell migration and proliferation